Navigation Links
TSC Global Awareness Day Scheduled for May 15
Date:5/2/2013

SILVER SPRING, Md., May 2, 2013 /PRNewswire-USNewswire/ -- On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the second annual TSC Global Awareness Day.  On this day, thousands of individuals and families affected by TSC will join together to increase public awareness of the rare disease and share their stories of hope for the future.

This year's TSC Global Awareness Day will also highlight the recent release of newly updated TSC clinical diagnosis, surveillance and maintenance guidelines. These guidelines, last updated in 1998, resulted from the 2012 TSC Clinical Consensus Conference, which brought together almost 100 of the world's top TSC experts.

"These updated criteria will significantly impact early diagnosis, leading to better treatment and an improved quality of life for anyone affected by TSC," said Kari Luther Rosbeck , President and CEO of the TS Alliance.

TSC is a genetic disorder that causes tumors to form in vital organs, primarily in the brain, eyes, heart, kidneys, skin and lungs.  It is also the leading genetic cause of both autism and epilepsy.  TSC is as common as Lou Gehrig 's disease or cystic fibrosis but is virtually unknown by the general population.

"One million people around the world are estimated to have TSC, with 50,000 or more right here in the United States," Rosbeck explained.  "Currently, there is no cure for TSC but ongoing research continues to be promising, not only for this disorder, but also for those suffering from autism, epilepsy and even cancer, because of TSC's relation to the same genetic pathway."

"At least two children born each day in the United States will have TSC," Rosbeck continued.  "However, many cases go undiagnosed due
'/>"/>

SOURCE Tuberous Sclerosis Alliance
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Algeta and Lumiphore Announce Further Expansion of Their Global Partnership for the Development of Targeted Alpha-pharmaceutical Cancer Therapeutics and Companion Diagnostics.
2. Hospira revela estrategia global para sus dispositivos
3. Hospira revela estratégia global para dispositivos
4. XBiotech to Present at UBS Global Healthcare Conference
5. GW Pharmaceuticals Announces Pricing of Initial Public Offering on the NASDAQ Global Market
6. Hospira Unveils Global Device Strategy
7. Deborah Autor, FDAs Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan
8. DebMed Supports World Health Organizations Global "Save Lives: Clean Your Hands Day" on May 5
9. Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
10. Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
11. Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Neurelis, Inc. ("Neurelis") today announced an agreement ... held by Biotie to purchase Neurelis, clearing the way ... diazepam) for pediatric and adult epilepsy patients who experience ... Biotie has advanced the development program for NRL-1 and ... work required for NDA submission to the FDA.  Given ...
(Date:7/10/2014)... , 11. Juli 2014  Dilon ... für die molekulare Bildgebung, einschließlich molekularer ... die CE-Zulassung für sein Navigator ® ... Dilon das Produkt jetzt europaweit vertreiben. ... Großteil der europäischen Länder ausgedehnt und ...
(Date:7/10/2014)... July 10, 2014  Breg, Inc., a premier ... launched the FreeRunner™ knee brace with new innovations ... patella mal-tracking return to active lifestyles.  FreeRunner,s patent-pending ... braces, providing support when patients need it most, ... don,t. Patellofemoral issues are the most ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... DUBLIN, Calif., April 14, 2011 Carl Zeiss ... microscope system at the 79th Annual Meeting of ... Denver, Colo. Based on the breakthrough OPMI® Pentero ... offers innovative new features and customer benefits such ...
... results from the largest multicenter clinical trial for heart ... International Society for Heart & Lung Transplantation (ISHLT) 31st ... show clinical benefit for the use of Everolimus in ... randomized patients at 67 medical centers spanning 5 continents. ...
Cached Medicine Technology:PENTERO 900: Elevating Excellence in Microsurgery to a New Level 2PENTERO 900: Elevating Excellence in Microsurgery to a New Level 3Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 2Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 3Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 4
(Date:7/12/2014)... injuries increase in the summer as people gather around fire ... most vulnerable to these seasonal fire hazards: children. "Young ... by putting their hands on the side of cooking grills," ... Loyola University Medical Center in Maywood, Ill., said in a ... play with fire, you get burned, is true -- ...
(Date:7/12/2014)... New York (PRWEB) July 12, 2014 ... to move forward in U.S. courts, Bernstein Liebhard LLP ... elevated metal ion levels to the failure of metal-on-metal ... 2nd issue of The Journal of Bone & Joint ... received unilateral Articular Surface Replacement prostheses at least twelve ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Doylestown Hospital ... a variety of men’s health questions. Paddock tackles ... to men, why women live longer than men, and ... Men's Health Made Simple featured on Doylestown Hospital’s ... a hernia at any age. If you notice pain, ...
(Date:7/12/2014)... Praeclarus Press is excited to ... new resource for women in need of lactation support. ... away from their children. Today’s mothers receive very clear ... but often feel unsupported when it comes to balancing ... evidence-based insights, and written by Nancy Mohrbacher, an international ...
(Date:7/12/2014)... 12, 2014 The largest pure occupational ... pleased to announce that it will be opening its ... facility will join four Atlanta-based Nova Medical Centers’ locations. ... 3209 Deans Bridge Road, and will be open from ... , “With Nova’s treatment philosophy of rapid return-to-work and ...
Breaking Medicine News(10 mins):Health News:Burn Injuries More Common in Summer 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2
... , The Authority offers patients consumer ... Advisories for improved patient safety , , ... Authority supports "National Patient Safety Day," Saturday, July 25, which is ... an active role in their healthcare. , , ...
... SHENYANG, China, July 24 /PRNewswire-Asia/ -- Neusoft Medical ... Neusoft Corporation,(600718.SH), officially announced that its newly developed Computed,Tomography(CT) ... by,the FDA recently, and is also marked as the ... multi-slice CT scanner was shipped to its U.S.-based customers,recently, ...
... and phosphate content is common, but labeling is not ... -- Additives used to "enhance" uncooked meat and poultry ... disease, researchers say. , Many fresh meat and poultry ... and flavorings that are not required to be listed ...
... , KENILWORTH, N.J., July 24 Schering-Plough ... settlement, subject to Court approval, to resolve litigation seeking to ... other forms of relief. The consolidated class action lawsuits, ... 2009, were filed in U.S. District Court for the District ...
... , DUBLIN, Ohio, July 24 Cardinal Health ... officer (CIO), effective Aug. 3. , , ... enterprise-wide information technology infrastructure and will work to enhance the ... report to George Barrett, who will become chairman and chief ...
... Dialysis Corporation of America (Nasdaq: DCAI ) announced today ... Wednesday August 5, 2009, after the close of the market. The ... second quarter 2009 earnings release the following morning, Thursday, August 6, ... Those interested in participating in the August 6, 2009 ...
Cached Medicine News:Health News:Pennsylvania Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Pennsylvania Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 2Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 3Health News:Fresh-Meat Additives May Be Dangerous for Kidney Patients 2Health News:Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck 2Health News:Cardinal Health Names Patricia Morrison Chief Information Officer 2Health News:Dialysis Corporation of America Announces Second Quarter 2009 Earnings Release Date 2
Introducer Sheath Designed for Vascular Access...
Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
... The Driver Stent design, ... surpasses the limitations of stainless ... makes possible thinner struts, for ... support. The Driver Coronary Stent ...
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: